Company description
In contrast to other RNA viruses, such as human immunodeficiency virus (HIV) and influenza, WNV exhibits a high degree of sequence conservation in its natural reservoir. Such sequence conservation makes WNV a promising target with regard to targeting humoral and cellular immune responses to conserved epitopes. Monoclonal antibody (mAb) has many advantages such as targeting to a single epitope, high specificity, stable passage, large-scale manufacturing and extensive applications in basic research, medical diagnosis, and tumor therapy. Armed with advanced technology, Creative Biolabs now provides anti-WNV mAbs as well as polyclonal antibodies (pAbs) products for research use. We can also provide a full comprehensive suite of secondary antibodies and isotype controls to meet your needs. Flexible customized solutions are available according to customer’s requirements.
